It is relatively easy to begin policy documents with a general assertion that ethics will be followed. Less obvious is how to ensure that day-to-day activities are consonant with ethical standards. We suggest that using day-to-day publication activities as the driver for building policies and procedures can promote ethical practices from the ground up. Although basic principles of ethical publication practice may seem straightforward to some, for others this information may require explanation, interpretation and context. Effective policy development includes big-picture items as well as more day-to-day tactical responsibilities such as those discussed below. Research questions, disciplinary practices, applications and team structures may vary. Thus, no single publication plan or policy solution is right for all teams. It is up to team members to review guidelines for best practices and find the optimal implementation for their situations.
| INTRODUCTION
Good publications are based on high-quality science, and high-quality science requires adherence to ethical principles. Medical publications ethics-broadly defined-are a key concern of many professional societies, such as the Committee on Publication Ethics (COPE) and the
International Society for Medical Publications Professionals (ISMPP).
The broad definition of ethics in the context of publications includes an array of beliefs and practices, from essential bioethical principles through to tactical efforts to comply with accepted guidelines and codes. The proliferation of associated guidance documents and codes (Table 1) requires considerable time and effort to read, synthesise and apply in day-to-day practice. Thus, in today's resource-constrained working environments, various publications professionals often take responsibility for staying abreast of these guidelines and setting strategies and developing day-to-day approaches that foster compliance. Yet, despite a general agreement that ethical publication practices are essential [1] [2] [3] [4] (Table 1) , logistical questions remain, largely as a result of differing interpretation of high-level principles. We advocate a focus on ethical practices in everyday publication activities that can then drive policies and procedures, promoting ethical practices "from the ground up".
It is relatively easy to begin policy documents with a general assertion that ethics will be followed. Less obvious are the exact practices that will be consonant with ethical standards and higher-level principles. For example, compliance with regulatory requirements and corporate integrity agreements may necessitate auditable, evidence-based publication plans or monitoring programmes to ensure timely and complete data dissemination, measures that are not an immediately obvious extension of high-level ethical principles like transparency. 2, [5] [6] [7] [8] [9] The first step is ensuring that ethical considerations, derived from both general principles and more tactical approaches, underpin each activity that contributes to publications planning, development and management. In other words, because the separation between everyday practice and grounding ethical principles is wide, we believe that beginning policies by considering the ethics of each step of a process can enhance compliance, creating a more thoughtful and effective working environment.
Variations in the use of terminology can create confusion; therefore, we begin this discussion with a few definitions. We use the term publication(s) practice(s) to include all activities associated with publications planning, development and management, including the work of medical writers and steering committee members as well as any other contributors to publications and publication plans. Publication plans are documents that outline specific logistical steps for publication practices and capture publication concepts for a specific team.
The best publication plans integrate regulatory and legal requirements, contextual dissemination of data, clinical relevance to patients and the intellectual interests that drive peer-reviewed publications. Publication development is not a precisely defined term. We use it
here to indicate activities (such as authoring and contributions) related to the production of an individual manuscript, poster or presentation.
In general, we use the term development to indicate activities required to produce some sort of product (such as a publication plan, policy document or manuscript). We use the term publication professional broadly and in keeping with the membership profile of ISMPP because experts with many titles such as publication manager, publication associate, medical writer or publication director may contribute to the planning and execution of publications.
What's known
• Medical publications should be developed following ethical principles.
What's new
Carefully considering the ethics inherent in each step of publication development will enhance the integrity of:
• publication policies
• publication plans
• authorship and contributorship
• transparency
• individual publications including abstracts, posters, oral presentations and manuscripts tabases, which will increasingly include study report summaries. In addition, many sponsors provide protocols, clinical study reports (CSRs), statistical analysis plans and/or anonymised patient-level data on their websites. [13] [14] [15] The increasing availability of study data without the context provided by a publication adds complexities to publication practices.
In practice, publications planning and management requires attention to general forms of transparency (or honesty), specific measures for data transparency as well as transparency regarding authorship and other contributions to manuscripts. Publication teams with clearly defined roles and responsibilities, as well as effective management of both processes and documents, are essential to fostering all types of transparency. 3, 7 Ideally, policies and procedures should be anchored in practices that promote transparency.
| Establishing roles and responsibilities
Not only do the minutiae of publication practice require specialised skills, but even small missteps can undermine transparency, casting integrity and accountability into doubt. 6, 7 In large-scale clinical trials or development programmes, each task necessary for publication development and management should be shared across teams with an appropriate spectrum of skills. In line with the latest two iterations of GPP, 6 ,7 a steering committee should be formed for studies or groups of studies expected to generate multiple related publications, to ensure consistency and efficiency of products and process steps.
However, simply forming a team is not enough. Table 2 for an example);
policies and procedures should reflect realistic thinking and expectations. In team settings, it is also important to apportion accountability for work products (such as planning documents or manuscript drafts)
to team members with the authority, ability and time to complete those tasks. For example, assigning accountability for draft manuscript development solely to a writer and not to the manuscript authors does not support best practices for ethical authorship.
True transparency is impossible without accuracy. To ensure both transparency and accuracy in data reporting, publications teams should designate a specific member to verify that data reported in publications are consistent with publicly available postings and that any differences are adequately explained. Some journals require these documents for the review process; hence, an appropriate team member should oversee that such documents are available. Top-tier journals may also publish redacted protocols as supplementary material to accompany the primary results of clinical trials. Effective publications management might suggest that this process occur in tandem with a final review of the publication by authors. All listed authors should be prepared to confirm the data accuracy in a manuscript and to accept public accountability for the content of the publication.
| Specialised roles of publications professionals
When reporting clinical study data, the use of professional medical writers should be discussed by a publications team, steering committee or clinical study team well before publication writing be- 
| Documentation and accountability
As observed above, transparency is an essential feature of publication ethics that extends beyond presenting clinical trial data; thus, T A B L E 2 Sample responsible, accountable, consulted, informed (RACI) table for developing a manuscript. Appropriate steps should be added, as per the appropriate operating procedure for the collaborating and sponsoring groups publication activities should be documented and auditable. Auditable documentation may include the publication plan, additional documents like the RACI (responsible, accountable, consulted, informed) chart (see Table 2 for an example), and records of reviews, author agreements and submission documentation. The specifics of a publication plan have been reported elsewhere and are discussed briefly below.
1,6,7
A publication plan is a critical part of publication management 1, 6, 7 that should be developed, maintained and regularly updated. The format of effective publication plans can vary widely. In some organisations with few employees or publications activities, slide sets or a spreadsheet that can be incorporated into larger clinical development or product planning documents may be adequate. Larger organisations or teams with more publications may prefer to use electronic tracking and reviewing tools to manage their deliverables. Gantt charts display events over time, may be associated with any data storage method, and can provide useful information to broader audiences. Steering committee and publication team members (whichever are applicable)
should have input into the format and handling of publication plans and updates, as consistent with policies and the steering committee charter. We recommend that all Phases 2 and 3 clinical development programmes have a separate, formal publication plan or formally integrate their planning within a clinical development, medical affairs, project management or data dissemination plan.
Regardless of format, publication plans should account for all presentations and manuscripts of specific datasets, including information about venues, timing, the names of relevant meetings and journals. 1 It may be helpful to include a schedule of planned steering committee or authoring group meetings, contact information and details about potential follow-up work such as meta-analyses, publications of secondary or tertiary outcomes data or book chapters.
Furthermore, publication plans should be accurate, complete and regularly reviewed and updated. 1, 6, 7 We recommend at least quarterly review of any stand-alone publication plan and that publication planning activities included in other documents (like a data dissemination plan) are reviewed each time these documents are updated. Steering committees, if formed, should be included in the regular review of publication plans, and such review should be mandated in policies and steering committee charters.
| Building publication policies
It may seem counterintuitive to discuss policy and process development after the logistics of team assignments and publication plans; however, an understanding of tactical information is essential to building high-quality policies and working instructions.
To be effective, publication policies and working guidelines must reflect best practices and ethics as well as local logistical realities.
Policies and working instructions should also identify the scope and types of documents covered; for example, meeting presentations, publication plans, steering committee charters or peer-reviewed publications. 3, 8 Policies or procedures should detail required steps for planning, development, review and approval of overall publication plans (Table 2 provides researchers and even patients. 1, 6, 7 Thus, all publication policies, like publication plans, should be subject to periodic review.
| DISCUSSION
Lack of transparency-of data, or authorship or trial conduct-in the past has eroded trust in pharmaceutical companies, research integrity and the medical profession. 11, 18 We believe that building a mutual vision for the transparent dissemination of clinical data with investigators, medical writers, statisticians and publication managers promotes a single voice that can be reflected in publication policies and plans.
Ensuring that all data, independent of the study outcome, are included in the publication plan fulfils the obligation of full transparency and validates that a good faith effort has been made to publicly disclose the study results, supporting research integrity. Furthermore, any activity that supports publications of trial data allows expert authors to contextualise results with current literature, comment on how the results may change clinical practice and expand on the minimum data allotted on clinical trial results repositories. In addition, such activity needs to be auditable to ensure the complete, transparent and ethical dissemination of the available data.
One barrier to the true transparency of publicly available materials that we have not addressed is accessibility to a broad range of reading levels. Ultimately, these data should be provided within an appropriate context for informed decision-making by patients and healthcare providers. 8, 9 Some journals include patients as manuscript reviewers to obtain a critical and often overlooked perspective, and the EMA is moving towards a requirement for "lay summaries", or information accessible to the general public. The increasing move towards making data more generally accessible makes peer-reviewed publications even more important. These papers are often the primary means by which expert and academic interpretations of study data are made available to prescribers and how the need for future studies is determined. Translational work, including systematic reviews and meta-analyses, that situate primary research within a larger scientific or clinical context, is also needed.
Although basic principles of ethical publication practice may seem straightforward to some, for others this information may require explanation, interpretation and context. Consider, for example, students and early-career scientists, publication planners and physicians still learning how bioethical concerns affect publications.
Effective policy development includes big-picture items as well as more day-to-day tactical responsibilities like those we have dis- 
